We believe that technology has the potential to revolutionize the healthcare sector. PharmAccess is an entrepreneurial organization dedicated to delivering healthcare solutions that leave no one behind.
With headquarters in Amsterdam and most of its staff based in four country offices across Africa, PharmAccess is an organization with a history of reimagining what is possible. We challenge the notion that exclusion from healthcare is an inevitable consequence of living in poorer countries and identify the opportunities and partners – both private and public, needed to bring about transformation.
PharmAccess aims to be an innovator and catalyst for practical changes that can be scaled up. It is introducing innovative financing mechanisms such as health insurance, and standards to assess and stimulate improvement of the quality of care delivered through SafeCare. The Medical Credit Fund, also part of the PharmAccess Group, is a blended financing vehicle and collaborates with local financial institutions to provide access to credit in the private health sector.
When Prof. Joep Lange founded PharmAccess in 2001, the objective was to turn ground-breaking research into action by bringing HIV/AIDS treatment to the people who needed it most.
Joep challenged the status quo, asking why a multinational like Coca-Cola could manage to deliver cold drinks to every corner of Africa, yet the world’s leading experts and public organizations could – or would – not do the same with life-saving drugs.
Unwilling to wait for public policies to change, Lange decided to go through the private sector instead, and started PharmAccess Foundation to set up workplace treatment programs in Africa. Heineken was the first company to commit, and many other multinationals followed. With a huge impact: it proved that it was possible to deliver lifesaving treatment to people in Africa, and that the delay in doing so was a question of political will.